Eric Lefkofsky’s technology company, called Tempus, recently received $80 million in funding from a group of key investors. With this new investment, the Chicago-based company is now worth $1.1 billion. This new net worth gives the company a “unicorn” status, which is something that can be difficult to achieve for startups like it.
The company specializes in collecting data to research cancer treatment trends, and they currently employ over 400 people, but Lefkofsky says that number is growing very quickly. About 30 new people hired each month, and that trend is expected to continue.
According to Lefkofsky, the company has built relationships with powerful organizations and individuals in the healthcare field. These include doctors and companies that are looking for ways to collect and utilize data to treat cancer patients in the most effective way. Lefkofsky says that the traction they’ve been able to gain in this field has been amazing and has lead to their success. Those contributing to the $80 million funding include New Enterprise Associates and Revolution Growth, among others.
Lefkofsky helped establish the company after his success co-founding Groupon and several other successful business ventures. He now serves as CEO of Tempus. After achieving business success, Lefkofsky established a charitable foundation in 2006, which provides initiatives to enhance communities. He also serves on the board of trustees for several organizations, including Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry, World Business Chicago, and Steppenwolf Theatre Company, where he serves as chairman of the board.
Adding to his list of impressive accolades, Lefkofsky also serves as an adjunct instructor at University of Chicago. He’s even written a book called Accelerated Disruption. He is a graduate of the University of Michigan, and he received a Juris Doctor from the University of Michigan’s school of law.